Company Filing History:
Years Active: 2025
Title: The Innovations of Matthew Roden
Introduction
Matthew Roden is an accomplished inventor based in Princeton, NJ. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents. His work focuses on innovative solutions for diagnosing and treating diseases.
Latest Patents
Matthew Roden holds a patent for "Nectin-4 binding miniproteins, conjugates and uses thereof." This patent includes polypeptides and conjugates, such as radionuclide conjugates, which are useful in compositions and methods for treating, diagnosing, monitoring, and imaging diseases associated with the expression of Nectin-4.
Career Highlights
Matthew is currently employed at Aktis Oncology, Inc., where he continues to advance his research and development efforts. His work is pivotal in creating new therapeutic options for patients.
Collaborations
He collaborates with notable colleagues, including William C Blackwell, III and Michael Lawrence Doligalski, to further enhance the impact of his innovations in the medical field.
Conclusion
Matthew Roden's contributions to biotechnology through his patent and work at Aktis Oncology, Inc. highlight his role as a key innovator in the industry. His efforts are paving the way for advancements in disease treatment and diagnosis.